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Abstract
In this paper we present the detailed clinical and cytogenetic analysis of a prenatally detected complex Congenital
Diaphragmatic Hernia (CDH) patient with a mosaic unbalanced translocation (5;12). High-resolution whole genome SNP
array confirmed a low-level mosaicism (20%) in uncultured cells, underlining the value of array technology for identification
studies. Subsequently, targeted Fluorescence In-Situ Hybridization in postmortem collected tissues demonstrated a similar
low-level mosaicism, independently of the affected status of the tissue. Thus, a higher incidence of the genetic aberration
in affected organs as lung and diaphragm cannot explain the severe phenotype of this complex CDH patient. Comparison
with other described chromosome 5p and 12p anomalies indicated that half of the features presented in our patient
(including the diaphragm defect) could be attributed to both chromosomal areas. In contrast, a few features such as the
palpebral downslant, the broad nasal bridge, the micrognathia, microcephaly, abnormal dermatoglyphics and IUGR better
fitted the 5p associated syndromes only. This study underlines the fact that low-level mosaicism can be associated with
severe birth defects including CDH. The contribution of mosaicism to human diseases and specifically to congenital
anomalies and spontaneous abortions becomes more and more accepted, although its phenotypic consequences are
poorly described phenomena leading to counseling issues. Therefore, thorough follow–up of mosaic aberrations such as
presented here is indicated in order to provide genetic counselors a more evidence based prediction of fetal prognosis in
the future.
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Introduction
CDH and somatic (chromosomal) mosaicism
Congenital Diaphragmatic Hernia (CDH) is a severe birth defect
characterized by defective formation of the diaphragm, lunghypo-
plasia and pulmonary hypertension. Its overall prevalence is 1/3000
live births and the majority are left sided. Associated anomalies
(i.e. non-isolated cases with or without an abnormal karyotype) are
involved in 60% of cases. The mortality rate is still high: 10–20% for
isolated and up to 40% for non-isolated cases. CDH is increasingly
detected by structural ultrasound in the second trimester of
pregnancy showing features like a mediastinal cardiac shift away
from the side of the defect and an intra-thoracic stomach bubble [1].
From a clinical point of view, early detection enables counseling by
a pediatric surgeon and/or clinical geneticist. Parents may opt for a
termination of pregnancy and in case of continuation; obstetric and
postnatal management can be optimized with referral to a
specialized tertiary centre with ECMO (Extra Corporal Membrane
Oxygenation) facilities.
The presumed multifactorial etiology of CDH is still poorly
understood. Yet, the identification of human chromosomal ‘‘hot
spots’’ presents strong evidence for a genetic component [2–3].
Because chromosomal aberrations are detected in 10–20% of the
cases, regular cytogenetic analysis by GTG-band karyotyping and
FISH are highly recommended in each patient [3]. In addition,
performance of high-resolution whole genome array could be
valuable, especially in case of additional malformations such as in
the cardiovascular system, genito-urinal tract and central nervous
system [4]. Furthermore, CDH may be part of a defined
syndrome, the most well recognized one being Fryns (OMIM
229850 with over 80% of the patients showing CDH, though its
locus remains elusive. Finally, CDH caused by tissue-limited
mosaicism, specifically of tetrasomy 12p, is rather common within
the Pallister-Killian syndrome (PKS)(OMIM 601803 [5]). How-
ever, in literature only a few other types of mosaic abnormalities
have been described in association with CDH [6–10]. Difficulties
in detecting (low-level) mosaicism and the former absence of
practical, high-resolution whole genome screening techniques
could partly account for these low incidences.
Mosaicism is defined as ‘‘the presence of a mixture of cells of
different genetic composition in a single organism’’ [11–12].
Advances in molecular cytogenetic techniques have allowed for a
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systematic whole genome screening of genetic aberrations among
others in mosaic form. Results indicated that such mosaicism
probably exists at a higher frequency than expected [12–13]. To
date, published studies on this topic both included screens of
diseased and (although very few) phenotypically normal individ-
uals and focused on single nucleotide mutations/polymorphisms
[14–15] as well as structural chromosomal aberrations/varia-
tions [16–23]. It is accepted that the phenotypic consequences of
these somatic mutations depend on the type of cells involved, the
nature of the initial mutation and its timing. Somatic mosaicism
is also known to produce often a milder phenotype than in its
non-mosaic form, allowing for survival of some disorders/
aneuploidies that would otherwise result in lethality. Germ-line
and somatic mosaicism are thus acknowledged as important
factors contributing to phenotypic variability [11]. Nonetheless,
in general the significance of somatic mosaicism usually remains
under-appreciated and performance of detailed postmortem
follow-up of the aberrations in multiple tissues is done only
rarely. Consequently, real understanding whether and how
chromosomal mosaicism has the potential to mediate tissue-
specific dysfunction in affected (and phenotypic normal)
individuals largely remains elusive.
In this case report we present the detailed clinical and molecular
cytogenetic analysis of a low-mosaic unbalanced translocation
(5;12) identified in a complex-CDH patient. The identification of
this specific chromosome aberration with high resolution whole
genome SNP array on umbilical cord blood shows the value of
array technology for identification studies, also in cases of low
mosaicism. Furthermore, we hypothesized in the patients’ affected
tissues a higher contribution of abnormal cells, which was assessed
by FISH analysis in several tissues. Finally, results of phenotype-
genotype correlations of each characteristic in this patient are
presented.
Materials and Methods
Routine Cytogenetic and targeted FISH analysis
Ethics approval was provided by the Medical Ethics Committee
of the Erasmus Medical Centre, Rotterdam, The Netherlands. A
written informed consent was obtained from all participants in this
study.
Sixteen ml of amniotic fluid (AF) was cultured using the in situ
method in BD Falcon Culture slides (VWR, Amsterdam, The
Netherlands) and subsequently used for both GTG-banded
karyotyping and fluorescence in situ hybridization (FISH).
Karyotyping of the parents was executed on GTG banded
metaphase spreads obtained from peripheral blood cultures.
Karyograms were reported according the ISCN rules. Fetal skin
and umbilical cord tissue were cultured according to standard
techniques and used for FISH analysis in a postnatal diagnostic
setting.
FISH experiments were performed according to standard
protocols with minor modifications and analyzed with an Axioplan
2 Imaging microscope (Zeiss, Sliedrecht, The Netherlands). Images
were captured using Isis software (MetaSystems, Altlussheim,
Germany). BAC clones were selected from the UCSC genome
browser (UC Santa Cruz, Santa Cruz, CA, http://genome.ucsc.
edu/cgi-bin/hgGateway, assembly March 2006) and purchased
from BACPAC Resources (Oakland,CA). BAC probes (Table S1)
were subsequently validated on control metaphases. Targeted whole
chromosome paints 5 and 12 and probes of the Cri-du-Chat/
Cornelia-de-Lange region were commercially available from
Eurodiagnostics (Arnhem, Netherlands) and Cytocell (http://
www.cytocell.com/products/aquarius/micro/cri.asp) respectively.
MLPA
DNA was isolated from 262 ml of uncultured AF using the
Chemagenic Magnetic Separation Module I (Chemagen, Baes-
weiler, Germany). MLPA analyses were performed using the
SALSA P036 and P070 kits of MRC-Holland (Amsterdam, the
Netherlands). These kits contain probes for all subtelomeric p-and-
q arm regions of all chromosomes. In addition, a specific
aneuploidy sensitive kit (P095) and a mental retardation focused
kit harbouring 6 probes in the 5p15 telomeric region were
executed. MLPA reactions were performed using the manufac-
turer’s protocol with minor modifications [24] and amplification
products were separated and quantified as described previously
[25]. Dosage ratio values of ,0.7 and .1.3 were used as
boundaries for deletions and duplications respectively with use of
specific calculated cut-off values in case of kit P095.
High resolution SNP array
High-resolution whole genome analysis was performed on
umbilical-cord blood derived DNA, using the Illumina Quad610
genotyping bead chip (Illumina, San Diego, CA, USA) according
to the manufacturer’s protocol. This array contains 598 821 SNP
probes distributed genome wide and an additional 21 890
intensity-only probes in regions where SNP coverage is poor.
Image intensities were extracted using the Illumina’s BeadScan
software. Data for each BeadChip were self-normalized in
Beadstudio GT (version 3.0+) using information contained within
the array (http://www.illumina.com/applications). CNVs were
detected by comparison to the common Illumina-reference set of
87 CEU samples specific for the Q610 array and visualized in
Nexus (version 4.1) software as log2 ratios (http://www.biodiscovery.
com/index/nexus). The analysis settings were as follow: SNP rank
segmentation with a significance threshold of 1610-6 and log-ratio-
thresholds of 0.2 and 20.2 for duplication and deletion respectively.
Mosaic changes were assessed by looking for aberrations in probe
intensities along with a shift in genotype frequencies of the SNP
probes (measured by b-allele frequencies).
FISH on paraffin embedded tissue of multiple samplings
and placental cryo-sections
Interphase FISH was performed on 4 mm thick paraffin
embedded tissue sections. The tissue sections were placed on
poly-L-Lysine coated slides. After deparaffinization using xylene,
slides were processed in 1 M NaSCN for 10 min at 80uC. Next,
pepsin digestion was optimized for each specific tissue type and
slides were dehydrated in alcohol. Denaturation of the probes was
carried out for 2 min at 95uC. Hybridization was performed at
37uC for 14-16 h. The slides were then washed in posthybridiza-
tion wash buffers at 55uC and 42uC for 365 min and
counterstained with DAPI. Signals were counted in at least 100
cells. Results were expressed as the percentage of chromosome 5p
signal (RP11-7M4, green) to control probe signal (RP11-90P7, red,
Table S1). Internationally accepted cut-off values of .15% of the
nuclei with one signal to identify deletions were adapted from the
available tumor tissue literature [26].The expected percentage in a
normal case is 100%; which means that there is no gene deletion.
Placental nuclear suspensions were harvested as described before
[27] and fixated in methanol/acetic acid. FISH was performed
according to local protocols.
Results
Patient report, Cytogenetic analysis and MLPA
A 22-year old Moroccan patient was referred to our tertiary
centre for follow up and genetic counseling of a CDH detected in
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PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15348
her unborn child by 20-weeks structural ultrasound in her first
pregnancy. The medical history was unremarkable. There was no
family history of congenital anomalies; however she and her
partner were consanguineous in the 2nd line. Ultrasound
examination revealed a defect in the left posterolateral diaphragm
and herniation of intestine, stomach and liver. Fetal biometry
measurements were on the 2nd percentile. Prognosis concerning
lung hypoplasia seemed critical with a lung head ratio of,1.0 (0.61
at 21 3/7 weeks) and an intrathoracic liver [28]. Amniocentesis was
performed at 20 weeks and 2 days.
Routine cytogenetic analysis confirmed the clinical suspicion of
a chromosomal abnormality and revealed a high-mosaic deletion
of chromosome 5 in cultured amniocytes which was confirmed by
FISH with probes specific for chromosome 5: the karyotype on
cultured AF cells was 46,XX,del(5)(p13.3)[27]/46,XX [4] (Table 1
and Table S1). Both parents had a normal karyotype. Based on the
paint result an unbalanced translocation was suspected. Therefore
MLPA with subtelomeric kits P036 and P070 was performed on
DNA isolated from uncultured amniotic fluid cells. Surprisingly,
results did not reveal such an anomaly showing normal relative
probe signals for all probes including the one on 5p. MLPA using
kit P096 which includes 6 probes within the Cri-Du-Chat (CDC)
critical region, showed a normal result as well, most probably
indicating a much lower level of mosaicism in uncultured AF cells
compared to cultured cells.
Based on the ultrasound and cytogenetic findings, the parents
decided to terminate the pregnancy at 23 1/7 weeks of gestation.
A female fetus was delivered vaginally and postmortem physical
examination showed a normally proportioned but intra-uterine
growth (length) restricted fetus; weight (490 gr: normal: 524+/
2116 gr), crown-rump length (17.5 cm; normal 20.8+/21.9 cm)
and foot-length 3.5 cm (normal:4.2+/20.5 cm). Dysmorphologi-
cal features were significant for the following: convex eye globes,
abnormal palpebral (down) slant, hypertelorism, wide nasal bridge,
flat philtrum, thin upperlip, micro-and-retrognathia and nuchal
wideness. Abnormal external ear development on both sides and
aberrant posterior rotation of the ears were noted as well.
Concerning the extremities, a palmar crease on the right was seen
and also an abnormal positioning of the anus with short perineum
and sacral dimple. Inspection of the internal organs presented a
large left diaphragmatic defect of the Bochdalek type with
herniation of stomach, duodenum and parts of colon, liver and
spleen. Further, this fetus showed severe lung hypoplasia (right
2.1gr, left 1.2 gr; lung-body ratio ,,0.015) and left kidney-
agenesis with compensatory right kidney hyperplasia. Finally,
autopsy demonstrated normal morphology of all remaining organs
and no structural aberrations of the brain on postmortem MRI.
The prenatally identified mosaicism 46,XX,del(5)(p13.3) in
cultured amniotic fluid cells was confirmed by postmortem
cytogenetic analysis in umbilical cord and skin tissue, yet in a
much lower frequency than expected (Table 1). Because the
suspicion of an unbalanced translocation persisted, yet not
confirmed by MLPA on uncultured cells, a whole genome SNP
array was applied.
High-Resolution SNP-array
High-resolution whole genome SNP array on DNA from umbilical
cord blood confirmed the 5p deletion and indeed identified a
coexisting chromosome 12p13.2 duplication by using information of
both log2 intensities and B-allele frequency as described recently
(Figure 1) [29]. These array results were subsequently confirmed by
FISH using chromosome 12 paint in addition to a 12p13.32 probe
on cultured AF (Figure 2). So, ultimately the patients karyotype could
be summarized as 46,XX,der(5)t(5;12)(p13.2;p12.3).arr 12p12.3
(rs7136701- rs10845353)x3,5p13.2(rs1108867-rs16903304)x1 (NCBI
Build 36/hg18 [30]). Considering the mosaic rate, B-allele ratios of
the array suggested a different level of mosaicism in the umbilical cord
blood as present in the cultured AF cells. The estimated percentage of
mosaicism based on these array results was 20%.
FISH on different paraffin embedded tissues and
cryosections of placenta
Considering the big difference between mosaic rates of cultured
amniocytes and umbilical cord blood as well as uncultured AF-
cells, we hypothesized that the genetic aberration rate could be
high in affected tissues (such as lungs, kidneys and diaphragm) and
lower in normal ones (heart, liver). Therefore we screened 7
different paraffin embedded tissues sections with FISH using
specific BAC clones. Results are summarized in Table 1; showing
no significant differences however in the levels of mosaicism
between normal and affected tissue. The derivative chromosome 5
was detected in 24–36% of the cells overall, confirming the array-
based estimated percentage of mosaicism. Finally, to assess a co-
existing placental mosaicism we also screened frozen sections of
placental tissue after nuclear isolation revealing mosaicism in 10%
of the nuclei.
Genotype-Phenotype comparison
Structural aberrations of chromosome region 5p (clinically
recognized as the Cri-du-Chat syndrome or as the Cornelia de
Lange syndrome) and 12p (featuring as PK syndrome or a pure
mosaic trisomy 12p) are both associated with CDH. Yet, for
chromosome 5p diaphragmatic hernia has only been associated
with Brachmann-de-Lange patients and not with those featuring
Cri-du-Chat. Subsequently, the diaphragmatic candidate region
on 5p most likely overlaps with the critical region of CdLS, taking
into account that CdLS patients are genetically heterogenous as
well. Hulinksy et al [31] identified a child with both CDH and
CdLS which had a pure interstitial deletion of 5p [del(5)(p13.1;
p14.2)]. Results of the comparison with this patient, and for all
Table 1. Detection of mosaicism using molecular cytogenetic
studies.
Detection
Period Method Tissue Mosaic level (%)
Prenatal GTG-band/FISH AF-c 87
MLPA AF normal
Postnatal FISH FUM 43 (38*)
DER 35 (23*)
SNP array UC-bl 20
FISH Parafin Embedded Heart 24
Liver 32
Diaphragm 26
Lung 29
Kidney 28
FISH Frozen Placental 13
DER 36
AF: Amniotic Fluid, AF-c: Amniotic Fluid-cultured.
DER: skin, FUM: Fibroblast culture UMbilical cord.
UC-bl: Umbilical Cord Blood;
*metaphase.
doi:10.1371/journal.pone.0015348.t001
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other characteristics in our patient compared to those described in
literature (for both regions) [32–33] [34–35] [36–37] are
summarized in Table S2. Based on these comparisons half of
the features present in our patient could be attributed to both
chromosomal areas. Exceptions to this were: the palpebral
downslant, the broad-nasal bridge, the retro-and micro-gnathia,
microcephaly, abnormal dermatoglyphics and IUGR, which
better fit the 5p associated syndromes.
Discussion
In this case report we present the detailed clinical and
cytogenetical analysis of a unique low-mosaic der (5) t(5;12)
aberration identified in a CDH patient with multiple congenital
anomalies. Classification of the true chromosome abnormality was
possible only after performance of a high-resolution whole genome
SNP array on uncultured umbilical cord blood. Application of this
Figure 1. Results High-resolution SNP array using uncultured umbilical cord bloodmaterial. A: Whole genome array: Log2 intensity (Top)
and B-Allele Frequencies BAF (Bottom). Top: Y-axis: Relative Copy Number State. X-axis: autosomes number 1–22 and the two sex chromosomes.
Displayed are the relative and normalized log2 intensities of all available SNPs on the array across the patients’ genome. At the beginning of
chromosome 5 a slight drop of log2 intensity is visible representing the deletion of part of the short arm of chromosome 5 in a low-mosaic state.
Similarly, the mosaic 12p duplication is depicted as a small peak of log2 intensity at the beginning of chromosome 12. Bottom: confirmation of
aberrations by the more clearly visible changes in BAF. B: Enlarged views of the results of chromosome 5 (left) and 12 (right) showing both the log2
intensity window as well as the BAF results.
doi:10.1371/journal.pone.0015348.g001
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technology in the identification of mosaic aberrations was reviewed
very recently [29]. Although mosaic abnormalities are increasingly
considered to be important factors in (spontaneous) abortions [38],
congenital anomalies [22,39–42] and in phenotypic variability,
analysis of multiple tissues in prenatal cases is done only rarely. In
addition, data on chromosomal mosaicism frequencies in phenotyp-
ically normal individuals, with the exception of studies in reproductive
tissues [13], is sparse as well [11,21]. While the clinical significance of
the aberrant cell line was quite obvious in our patient due to the
presence of major associated birth defects, this is not always the case.
Therefore, the recent availability of more sensitive and easier
applicable techniques will lead to increased detection of low-mosaic
aberrations at a prenatal stage and subsequently lead to more genetic
counseling problems. Extensive follow–up of mosaic aberrations in
affected cohorts as well as research of the incidence in the normal
population is indicated in order to provide genetic counselors a more
evidence based prediction of fetal prognosis in the future.
Phenotypic variability at the tissue level correlated to
mosaic frequency?
Because the mosaic aberration was present in both placenta-
and embryonic material we suggest that the translocation (and
subsequent loss of the ‘‘other’’ balanced translocation product)
occurred as a very early mitotic event in an initially normal
diploid zygote. More specifically, this may have occurred at least
before differentiation of trophoblast and inner cell mass in the
16-cell stage. To explain the phenotypic variability at the tissue
level, we speculated that the malformations of lungs, diaphragm
and kidneys would associate with a much higher level of
mosaicism than the normally developed tissues of heart and liver.
This would thus mirror a situation in which the post zygotic
mutation arose in an important lung-and diaphragm specific
precursor cell population and time window. However, such a
linear correlation between level of mosaicism and tissue
pathophysiology could not be confirmed in our case. Associa-
tions between the severity of the (whole) clinical phenotype and
the percentage of abnormal cells are generally known for the
most common autosomal aneuploidy (trisomy 21), yet the
mechanism by which this aneuploidy results in the complex
heterogeneous phenotype cannot be attributed to mosaicism
alone and is therefore still under discussion [43–44]. Differences
in default gene-expression profile requirements between tissues,
and subsequently variable susceptibility for loss or gain of
different chromosome areas could account for the tissue specific
Figure 2. Fluorescent In-Situ Hybridization results using cultured amniotic fluid and skin material. A: Left: Schematic representation of
the unbalanced der(5)t(5;12)(p13.2;p12.3) and its normal chromosome 12 counterpart. Right: Partial Karyotype of the patient showing both the
normal and abnormal chromosome 5 and both normal chromosomes 12. B: Fluorescent In-Situ Hybridization (FISH) on a metaphase spread of 1
umbilical cord-fibroblast-cell presenting 1 copy of BAC clone RP11-7M4 (Green) on the normal chromosome 5 and 3 of clone RP11-62P15 (red) on
both chromosomes 12 and the der(5) C: Whole-Chromosome Paint FISH results of 1 AF-cell showing duplication of part of the short arm of
chromosome 12 (WCP12: red) at the expense of part of 1 copy of chromosome 5 (WCP5:green).
doi:10.1371/journal.pone.0015348.g002
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pathology in multi-system diseases in general and in mosaic
states as well.
Finally, uncultured tissues are in general better able to reveal
true chromosomal mosaicism frequencies as compared to cultured
tissues, since culturing may introduce a selection bias that distorts
the percentages of abnormal cells. However we were not able to
detect the low-mosaic der (5) in uncultured AF-cells using MLPA,
yet did detect a high-mosaic der(5) in cultured AF cells. From this
it can be concluded that the level of mosaicism in uncultured cells
was probably too low to be detected with MLPA. These kind of
discrepancies have been described in some areas of tissue-specific
mosaicism, like mosaic trisomy 20 [45]. However, in the present
case there were no clues at all for tissue limited mosaicism as
explained above.
Mosaic unbalanced translocation (5;12) and CDH
Chromosomal abnormalities are detected in 9.5%–34% of
prenatally diagnosed CDH cases [46]. The most common
identified aneuploidy is trisomy 18 and smaller structural
rearrangements (microdeletions/duplications) of the distal arms
of chromosome 1q, 8p and 15q are relatively common in complex-
CDH subjects as well. However, structural abnormalities of almost
all chromosomes in association with diaphragm defects have been
described in literature, including those of the short arms of
chromosomes 5 and 12 [London medical Databases version
1.0.19]. Unfortunately, the candidate genes responsible for
malformation of the diaphragm remain to be determined for both
these regions, yet literature suggests that the candidate region for
diaphragm defects on 5p most likely overlaps with the CdLS
critical region only. In 2004 Krantz et al. [33] described a child
with classical symptoms of CdLS and a balanced, de novo
t(5;13)(p13.1;q12.1) thereby disrupting the NIPBL gene. However,
this child did not show a diaphragm defect. In contrast, Hulinksy
et al [31] did identify a child with the CdLS phenotype, CDH and
a pure interstitial deletion of 5p (del(5)(p13.1;p14.2)). Whether
NIPBL is indeed the causative gene for CdLS associated
diaphragm defects needs to be determined. In our own CDH
cohort we have 1 patient with both the CdLS-phenotype and a
mutation in exon 9 of the NIPBL gene. However, since CDH is
only rarely associated with CdLS (5%) and routine NIPBL
mutation screening is only recently been put into standard
practice, more specific cases featuring both need to be determined.
It is also possible, that a combination of CDH and CdLS is often
lethal and therefore rarely notified. Low-mosaicism in our case
may have caused changes in the (severity) of the CdLS phenotype
as repeatedly suggested in literature.
We also compared our patients remaining characteristics to the
features described in literature for both genomic areas. Based on
this comparison half of the features presented in our patient could
be attributed to both chromosomal areas, while some were more
associated with the 5p region. Hulinksy et al. [31] suggested that
some of the atypical CdLS characteristics in their patient
(hypoplastic kidneys, adrenal gland abnormalities and multipele
cysts) are caused by haploinsufficiency of other 5p13.1- p14.2
genes. However, retrospective analysis of our patients’ MRI did
not show evidence for cysts and adrenal gland defects. Moreover,
renal abnormalities (primarily vesicouretral reflux and cysts) are
described for CdLS after all. Since our case is not a pure
monosomy and very early prenatal dysmorphology hampers
identification of some clinical features, direct comparison between
this literature case and our patient remains troublesome.
Focusing on CDH and genetic mosaicism: the earlier mentioned
Pallister-Killian syndrome is the most common CDH-associated
syndrome caused by tissue-limited mosaicism. In a small study
more than ten years ago, Donnenfeld et al [47] tried to evaluate
the overall percentage of tissue-specific mosaicism among fetuses
with prenatally diagnosed diaphragmatic hernia and found in one
out of 13 fetuses a mosaic isochromosome 12p. However, the
diagnostic techniques used in this study were limited and the
number of investigated patients low. Only a few other case-reports
on CDH and genetic mosaicism have been published since,
featuring the chromosomes Y and 16. None have described a
mosaic der 5 t(5;12).
Mosaicism and detection with high–resolution SNP array
In general it is very difficult to estimate the true incidence and
significance of genetic mosaicism in human congenital anomalies.
The application of high-resolution SNP arrays allows for an easier
and more sensitive detection of this type of genetic aberrations for
several reasons. First, SNP arrays are shown to be able to detect
levels of mosaicism as low as 5% using the B-allele frequency as a
more sensitive measurement compared to the more difficult
detection of subtle down- or up crease of log R ratios (which only
can be used in Oligo based arrays). Second, the possible use of low
amounts of DNA from any kind of (uncultured) tissue diminishes
the technical failures due to the in-vitro cell culturing process [29].
So, the wide application of these methodologies in diagnostic and
research settings will increase our knowledge and ability to
diagnose patients with chromosomal mosaicism and allow for
better genotype-phenotype correlations.
Supporting Information
Table S1 Molecular-Cytogenetic results of the mosaic
unbalanced translocation (5;12) in several affected and
un-affected tissues.
(XLS)
Table S2 Phenotypic comparison of our patients’
characteristics with clinical info of the involved chro-
mosomal regions known from literature.
(XLS)
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